Dona N. Ho

2.2k total citations
18 papers, 485 citations indexed

About

Dona N. Ho is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Dona N. Ho has authored 18 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Genetics. Recurrent topics in Dona N. Ho's work include Genomics and Phylogenetic Studies (4 papers), Viral-associated cancers and disorders (4 papers) and Cancer Genomics and Diagnostics (4 papers). Dona N. Ho is often cited by papers focused on Genomics and Phylogenetic Studies (4 papers), Viral-associated cancers and disorders (4 papers) and Cancer Genomics and Diagnostics (4 papers). Dona N. Ho collaborates with scholars based in Hong Kong, China and United States. Dona N. Ho's co-authors include Edmond S.K., Chun Hang Au, Tsun Leung Chan, Aks Chiang, Kwai Fung Hui, Sai Wah Tsao, Jaap M. Middeldorp, George S.W. Tsao, Chi Man Tsang and Ava Kwong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and PLoS ONE.

In The Last Decade

Dona N. Ho

17 papers receiving 481 citations

Peers

Countries citing papers authored by Dona N. Ho

Since Specialization

Citations

This map shows the geographic impact of Dona N. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dona N. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dona N. Ho more than expected).

Fields of papers citing papers by Dona N. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dona N. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dona N. Ho. The network helps show where Dona N. Ho may publish in the future.

Co-authorship network of co-authors of Dona N. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Dona N. Ho. A scholar is included among the top collaborators of Dona N. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dona N. Ho. Dona N. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A multi-modal molecular characterization of the Philadelphia translocation featuring long read sequencing 2025 ·Gene ·(unknown), Chun Hang Au, Amy Wing-Sze Leung, Henry C. M. Leung, Elaine Yue Ling Wong, (unknown), Dona N. Ho, (unknown), (unknown), Edmond Chiu, Chor Sang Chim, Raymond Liang, Thomas S. K. Wan, Edmond S.K.	0
2	Rapid Breakpoint Mapping of a Novel Germline PALB2 Duplication by PCR-Free Long-Read Sequencing for Interpretation of Its Pathogenicity 2021 ·JCO Precision Oncology ·Ava Kwong, Chun Hang Au, Vivian Y. Shin, Dona N. Ho, Elaine Y. L. Wong, (unknown), (unknown), Tsun Leung Chan, Edmond S.K.	1
3	Rapid and economical drug resistance profiling with Nanopore MinION for clinical specimens with low bacillary burden of Mycobacterium tuberculosis 2020 ·BMC Research Notes ·(unknown), Chun Hang Au, (unknown), Henry C. M. Leung, Dona N. Ho, Elaine Yue Ling Wong, Tak‐Wah Lam, Tsun Leung Chan, Edmond S.K., (unknown)	20
4	Somatic mutation profiling in BRCA-negative breast and ovarian cancer patients by multigene panel sequencing. 2020 ·PubMed ·Ava Kwong, (unknown), Vivian Y. Shin, (unknown), Chun Hang Au, Dona N. Ho, (unknown), (unknown), Jiawei Chen, Karen K. L. Chan, Hys Ngan, Tsun‐Leung Chan, Edmond S.K.	10
5	Rapid detection of chromosomal translocation and precise breakpoint characterization in acute myeloid leukemia by nanopore long-read sequencing 2019 ·Cancer Genetics ·Chun Hang Au, Dona N. Ho, (unknown), Thomas S. K. Wan, Margaret H.L. Ng, Edmond Chiu, Tsun Leung Chan, Edmond S.K.	27
6	Potential Utility of Metagenomic Sequencing for Improving Etiologic Diagnosis of Infective Endocarditis 2019 ·Future Cardiology ·(unknown), Chun Hang Au, (unknown), Dona N. Ho, Dinghua Li, Tsun‐Leung Chan, Tak‐Wah Lam, Edmond S.K., (unknown)	15
7	Draft Genome Sequence of Helicobacter cinaedi, Compiled by Direct Whole-Genome Sequencing of a Blood Culture-Positive Isolate in Hong Kong 2018 ·Microbiology Resource Announcements ·(unknown), Chun Hang Au, (unknown), Dona N. Ho, Tsun‐Leung Chan, Tak‐Wah Lam, Edmond S.K., (unknown)	2
8	BAMClipper: removing primers from alignments to minimize false-negative mutations in amplicon next-generation sequencing 2017 ·Scientific Reports ·Chun Hang Au, Dona N. Ho, Ava Kwong, Tsun Leung Chan, Edmond S.K.	24
9	Next-generation sequencing and molecular cytogenetic characterization of ETV6-LYN fusion due to chromosomes 1, 8 and 12 rearrangement in acute myeloid leukemia 2017 ·Cancer Genetics ·Edmond S.K., Thomas S. K. Wan, Chun Hang Au, Dona N. Ho, (unknown), Margaret H.L. Ng, Tsun Leung Chan	12
10	Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms 2016 ·Diagnostic Pathology ·Chun Hang Au, (unknown), Dona N. Ho, Tsun Leung Chan, Edmond S.K.	62
11	Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel 2016 ·Journal of Molecular Diagnostics ·Ava Kwong, Vivian Y. Shin, Chun Hang Au, F. B. F. Law, Dona N. Ho, (unknown), (unknown), (unknown), (unknown), (unknown), James M. Ford, Edmond S.K., Tsun Leung Chan	36
12	Germline RECQL mutations in high risk Chinese breast cancer patients 2016 ·Breast Cancer Research and Treatment ·Ava Kwong, Vivian Y. Shin, Isabella Cheuk, Jiawei Chen, Chun Hang Au, Dona N. Ho, Tsun Leung Chan, Edmond S.K., Mohammad R. Akbari, Steven A. Narod	20
13	Homoharringtonine (omacetaxine mepesuccinate) as an adjunct forFLT3-ITD acute myeloid leukemia 2016 ·Science Translational Medicine ·Stephen S.Y. Lam, (unknown), Bai‐Liang He, (unknown), (unknown), (unknown), (unknown), Harinder Gill, Alice M.S. Cheung, (unknown), C.C So, Jérôme Tamburini, Chi Wai Eric So, Dona N. Ho, Chun Hang Au, Tsun‐Leung Chan, Edmond S.K., Raymond Liang, Yok‐Lam Kwong, Anskar Y.H. Leung	51
14	Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies 2015 ·PLoS ONE ·(unknown), Dona N. Ho, Kwai Fung Hui, Richard Yi Tsun Kao, Aks Chiang	19
15	Bortezomib and SAHA Synergistically Induce ROS-Driven Caspase-Dependent Apoptosis of Nasopharyngeal Carcinoma and Block Replication of Epstein–Barr Virus 2013 ·Molecular Cancer Therapeutics ·Kwai Fung Hui, (unknown), Dona N. Ho, Sai Wah Tsao, Aks Chiang	64
16	Activation of lytic cycle of Epstein‐Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma 2012 ·International Journal of Cancer ·Kwai Fung Hui, Dona N. Ho, Chi Man Tsang, Jaap M. Middeldorp, George S.W. Tsao, Aks Chiang	71
17	The crystal structure and mutational analysis of a novel RNA-binding domain found in the human Tap nuclear mRNA export factor 2002 ·Proceedings of the National Academy of Sciences ·Dona N. Ho, Glen A. Coburn, Yibin Kang, Bryan R. Cullen, Millie M. Georgiadis	28
18	Using viral species specificity to define a critical protein/RNA interaction surface 2001 ·Genes & Development ·Glen A. Coburn, Heather L. Wiegand, Yibin Kang, Dona N. Ho, Millie M. Georgiadis, Bryan R. Cullen	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact